Table 2.
Characteristics | Total (N) | Odds ratio in KNSTRN expression | P value |
---|---|---|---|
T stage (T1 vs. T2-4) | 510 | 1.04 (1.02-1.07) | <0.001 |
N stage (N0 vs. N1-3) | 501 | 1.02 (1.01-1.04) | 0.01 |
M stage (M0 vs. M1) | 369 | 1.02 (0.99-1.05) | 0.099 |
Clinical stage (Stage I vs. Stage II-IV) | 505 | 1.03 (1.01-1.05) | 0.003 |
Tumor status (Tumor free vs. With tumor) | 457 | 1.03 (1.01-1.05) | 0.002 |
Primary therapy outcome (CR-SD vs. PD) | 426 | 1.04 (1.02-1.07) | <0.001 |
Anatomic subdivision (Left vs. Right) | 498 | 1.01 (0.99-1.02) | 0.547 |
TP53 mutation (No vs. Yes) | 508 | 1.04 (1.02-1.06) | <0.001 |